{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:17:43Z","timestamp":1791926263201,"version":"4.3.4"},"reference-count":30,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0061","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:27:14Z","timestamp":1525253234000},"source":"Crossref","is-referenced-by-count":80,"title":["The Differential Diagnosis and Treatment of Atypical Parkinsonism"],"prefix":"10.3238","author":[{"given":"Johannes","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Arzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"10.3238\/arztebl.2016.0061_ref1","doi-asserted-by":"crossref","unstructured":"Dickson DW: Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med 2012; 2. pii: a009258","DOI":"10.1101\/cshperspect.a009258"},{"key":"10.3238\/arztebl.2016.0061_ref2","doi-asserted-by":"crossref","unstructured":"Wakabayashi K, Takahashi H: Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 2004; 24: 79\u201386","DOI":"10.1111\/j.1440-1789.2003.00543.x"},{"key":"10.3238\/arztebl.2016.0061_ref3","doi-asserted-by":"crossref","unstructured":"Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 2008; 5: 118\u201321","DOI":"10.1159\/000113679"},{"key":"10.3238\/arztebl.2016.0061_ref4","doi-asserted-by":"crossref","unstructured":"Lim J, Yue Z. Neuronal aggregates: formation, clearance, and spreading. Dev Cell 2015; 32: 491\u2013501","DOI":"10.1016\/j.devcel.2015.02.002"},{"key":"10.3238\/arztebl.2016.0061_ref5","doi-asserted-by":"crossref","unstructured":"McKeith IG, Dickson DW, Lowe J, et al., Consortium on DLB: Diagnosis and management of dementia with Lewy bodies: third report of the DLK Consortium. Neurology 2005; 65: 1863\u201372","DOI":"10.1212\/WNL.65.12.1992-a"},{"key":"10.3238\/arztebl.2016.0061_ref6","doi-asserted-by":"crossref","unstructured":"Vann Jones SA, O'Brien JT: The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 2014; 44: 673\u201383","DOI":"10.1017\/S0033291713000494"},{"key":"10.3238\/arztebl.2016.0061_ref7","doi-asserted-by":"crossref","unstructured":"Karantzoulis S, Galvin JE: Distinguishing Alzheimer's disease from other major forms of dementia. Expert Rev Neurother 2011; 11: 1579\u201391 MEDLINE","DOI":"10.1586\/ern.11.155"},{"key":"10.3238\/arztebl.2016.0061_ref8","doi-asserted-by":"crossref","unstructured":"Geser F, Wenning GK, Poewe W, McKeith I: How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005; 20 Suppl 12: S11\u201320","DOI":"10.1002\/mds.20535"},{"key":"10.3238\/arztebl.2016.0061_ref9","doi-asserted-by":"crossref","unstructured":"Watson R, Blamire AM, O'Brien JT: Magnetic resonance imaging in lewy body dementias. Dement Geriatr Cogn Disord 2009; 28: 493\u2013506","DOI":"10.1159\/000264614"},{"key":"10.3238\/arztebl.2016.0061_ref10","doi-asserted-by":"crossref","unstructured":"Mak E, Su L, Williams GB, O'Brien JT: Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther 2014; 6: 18","DOI":"10.1186\/alzrt248"},{"key":"10.3238\/arztebl.2016.0061_ref11","doi-asserted-by":"crossref","unstructured":"Perneczky R, Drzezga A, Boecker H, F\u00f6rstl H, Kurz A, H\u00e4ussermann P: Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 2008; 25: 531\u20138","DOI":"10.1159\/000132084"},{"key":"10.3238\/arztebl.2016.0061_ref12","doi-asserted-by":"crossref","unstructured":"Donaghy P, Thomas AJ, O'Brien JT: Amyloid PET imaging in Lewy body disorders. Am J Geriatr Psychiatry 2015; 23: 23\u201337","DOI":"10.1016\/j.jagp.2013.03.001"},{"key":"10.3238\/arztebl.2016.0061_ref13","unstructured":"Eggert K; Oertel W, Reichmann H, et al.: Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie: Parkinson-Syndrome. Deutsche Gesellschaft f\u00fcr Neurologie 2012."},{"key":"10.3238\/arztebl.2016.0061_ref14","doi-asserted-by":"crossref","unstructured":"Fanciulli A, Wenning GK: Multiple-system atrophy. N Engl J Med 2015; 372: 1375\u20136","DOI":"10.1056\/NEJMc1501657"},{"key":"10.3238\/arztebl.2016.0061_ref15","doi-asserted-by":"crossref","unstructured":"K\u00f6llensperger M, Geser F, Seppi K, et al., European MSA Study Group: Red flags for multiple system atrophy. Mov Disord 2008; 23: 1093\u20139","DOI":"10.1002\/mds.21992"},{"key":"10.3238\/arztebl.2016.0061_ref16","doi-asserted-by":"crossref","unstructured":"Gilman S, Wenning GK, Low PA, et al.: Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670\u20136","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"10.3238\/arztebl.2016.0061_ref17","doi-asserted-by":"crossref","unstructured":"Mahlknecht P, Schocke M, Seppi K: [Differential diagnosis of parkinsonian syndromes using MRI]. Nervenarzt 2010; 81: 1168\u201379","DOI":"10.1007\/s00115-010-3022-8"},{"key":"10.3238\/arztebl.2016.0061_ref18","doi-asserted-by":"crossref","unstructured":"Constantinescu R, Richard I, Kurlan R: Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord 2007; 22: 2141\u20138","DOI":"10.1002\/mds.21578"},{"key":"10.3238\/arztebl.2016.0061_ref19","doi-asserted-by":"crossref","unstructured":"Schrag A, Geser F, Stampfer-Kountchev M, et al., European MSA-Study Group: Health-related quality of life in multiple system atrophy. Mov Disord 2006; 21: 809\u201315","DOI":"10.1002\/mds.20808"},{"key":"10.3238\/arztebl.2016.0061_ref20","doi-asserted-by":"crossref","unstructured":"Stamelou M, de Silva R, Arias-Carri\u00f3n O, et al.: Rational therapeutic approaches to progressive supranuclear palsy. Brain 2010; 133: 1578\u201390","DOI":"10.1093\/brain\/awq115"},{"key":"10.3238\/arztebl.2016.0061_ref21","doi-asserted-by":"crossref","unstructured":"Respondek G, Stamelou M, Kurz C, et al.: Movement Disorder Society-endorsed PSP Study Group. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 2014; 29: 1758\u201366","DOI":"10.1002\/mds.26054"},{"key":"10.3238\/arztebl.2016.0061_ref22","doi-asserted-by":"crossref","unstructured":"Litvan I, Agid Y, Calne D, et al.: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1\u20139","DOI":"10.1212\/WNL.47.1.1"},{"key":"10.3238\/arztebl.2016.0061_ref23","doi-asserted-by":"crossref","unstructured":"Stamelou M, Knake S, Oertel WH, H\u00f6glinger GU: Magnetic resonance imaging in progressive supranuclear palsy. J Neurol 2011; 258: 549\u201358","DOI":"10.1007\/s00415-010-5865-0"},{"key":"10.3238\/arztebl.2016.0061_ref24","doi-asserted-by":"crossref","unstructured":"Armstrong MJ, Litvan I, Lang AE, et al.: Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496\u2013503","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"10.3238\/arztebl.2016.0061_ref25","doi-asserted-by":"crossref","unstructured":"Ling H, O'Sullivan SS, Holton JL, et al.: Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010; 133: 2045\u201357","DOI":"10.1093\/brain\/awq123"},{"key":"10.3238\/arztebl.2016.0061_ref26","doi-asserted-by":"crossref","unstructured":"Wenning GK, Litvan I, Jankovic J, et al.: Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184\u20139","DOI":"10.1136\/jnnp.64.2.184"},{"key":"10.3238\/arztebl.2016.0061_ref27","unstructured":"Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 1967; 92: 23\u20136."},{"key":"10.3238\/arztebl.2016.0061_ref28","doi-asserted-by":"crossref","unstructured":"Vanek Z, Jankovic J: Dystonia in corticobasal degeneration. Mov Disord 2001; 16: 252\u20137","DOI":"10.1002\/mds.1038"},{"key":"10.3238\/arztebl.2016.0061_ref29","doi-asserted-by":"crossref","unstructured":"Wagner J, Ryazanov S, Leonov A, et al.: Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol 2013; 125: 795\u2013813","DOI":"10.1007\/s00401-013-1114-9"},{"key":"10.3238\/arztebl.2016.0061_ref30","doi-asserted-by":"crossref","unstructured":"Castillo-Carranza DL, Guerrero-Mu\u00f1oz MJ, Sengupta U, et al.: Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model. J Neurosci 2015; 35: 4857\u201368","DOI":"10.1523\/JNEUROSCI.4989-14.2015"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:11:59Z","timestamp":1638796319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0061","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]}}}